Improvement of [beta]-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control

Background Achieving euglycaemia by continuous subcutaneous insulin infusion (CSII) therapy alone has been shown to restore [beta]-cell function in patients with newly diagnosed type 2 diabetes. However, the efficacy has not been evaluated in patients with non-newly diagnosed type 2 diabetes and sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes/metabolism research and reviews 2013-09, Vol.29 (6), p.473
Hauptverfasser: Choi, Soo-Bong, Lee, Jun-Ho, Lee, Ju-Han, Kim, Seonguk, Han, Sang-Don, Kim, Ick-Hee, Noh, Yun-Hee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!